🔗 Share this article

As America continues making historic adjustments to its vaccination guidelines, one figure appears in a surprising turn: Tracy Beth Høeg, a US-based physician and epidemiologist who first made her name by expressing skepticism about Covid shots during the pandemic and has concentrated on possible fatalities after Covid vaccination in her short position at the FDA.

Planned Changes to Pediatric Immunization Schedule

Agency leaders planned to unveil radical changes to the childhood vaccine schedule in December, aligning the US with the Danish vaccine program, according to reports – a substantial departure that would place the US at odds with much of the international standard with insufficient data for benefit. The planned update has been pushed back until the next year.

Instead of the top vaccines chief, Tracy Beth Høeg is listed to present at the gathering. She was newly appointed interim head of the FDA’s Center for Drug Evaluation and Research (CDER), the fifth individual to run the division this calendar year.

A New Direction at the Regulatory Body

The acting appointment could signify a closer partnership between the drug and biologics divisions as Dr. Høeg and Prasad consolidate power at the FDA – and it points to a increased emphasis upon dismantling long-standing immunizations at the FDA.

Dr. Høeg has frequently advocated for ending specific pediatric immunization guidelines in the US in order to be more like Denmark, a country with comprehensive healthcare and a population about the size of Wisconsin’s.

In her initial comments, she has kept her attention on immunizations – typically the domain of Dr. Prasad, head of the FDA’s CBER – rather than drug regulation.

Doubts Over Qualifications

The appointee has little discernible background in medication creation, oversight or management, which has been typical for former heads of the biologics center. She has worked at the FDA as a top consultant to the commissioner and the vaccine center since earlier this year.

“It seems she lacks to have the necessary background” for running the CDER, remarked Jonathan Howard. “She lacks experience running a clinical trial. She lacks experience in managing a major agency. She is not an expert in industry regulation.”

Previous directors of the center would “be deeply familiar with legal statutes and the research of medication creation”, said Dr. Janet Woodcock. “Objectively, she lacks the kind of background that previous people who led the center have had.”

This division has an enormous range of responsibilities at the agency, she emphasized.

“Many people just zeroes in on the novel medication approvals, but the generic drug division approves thousands of off-brand pharmaceuticals. There’s a biologic copycat branch, non-prescription drug unit and other areas, and every single one must be looked after,” Dr. Woodcock noted. “The responsibility you neglect, that’s the thing that I always told people is going to come back to haunt you.”

Furthermore, a substantial administrative aspect to the role, which manages in excess of 5,000 personnel. “It’s a huge leadership role, if you perform it correctly,” Woodcock added.

Agency Reaction and Contentious Policies

In response to questions about Dr. Høeg's credentials and whether this assignment represents more teamwork among FDA leaders on immunizations, a press secretary said that the “inquiries stem from incorrect premises”.

“Her resume aligns with the duties of her job,” the official stated, noting the period Høeg spent guiding the agency head on “drug safety and oversight research, including computational safety modeling and shot safety tracking”.

As the temporary head, Dr. Høeg assumes responsibility for the agency head's new expedited review system, a disputed one-day therapy clearance system that reportedly troubled her predecessors. “By what process are these therapies being selected for this fast-track system? Who takes the choices?” Dr. Howard asked. “There’s a lot of confidentiality happening at the regulatory body right now.”

Overall, he stated, “the agency looks to be trending towards laxer regulations of most medications, aside from immunizations.”

Documented History on Vaccines

Concerning vaccines, Høeg has a more documented, if concerning, track record, some experts have noted. She released a research paper using unverified crowd-sourced reports to assess the incidence of heart inflammation following COVID-19 vaccination. She consulted for the state of Florida surgeon general Joseph Ladapo, who reportedly have modified findings to suggest Covid vaccinations are more dangerous than they are.

Among her “policy goals” for the incoming administration included revising rules for recently developed shots and discontinuing “optional” immunizations, she remarked post-election on a audio program. At the FDA, Høeg has allegedly suggested preventing adolescent males from obtaining Covid vaccinations.

“She is an all-around ideologue who begins with her beliefs and reverse-engineers to fit the data in a highly disingenuous, dishonest manner,” Dr. Howard said.

Consolidating Power and a “Campaign of Retribution”

Dr. Høeg joined other contrarians, {like|